Your browser doesn't support javascript.
Impact of HFNC application on mortality and intensive care length of stay in acute respiratory failure secondary to COVID-19 pneumonia.
Sayan, Ismet; Altinay, Mustafa; Çinar, Ayse Surhan; Türk, Hacer Sebnem; Peker, Nebia; Sahin, Kerim; Coskun, Nurcan; Demir, Gamze Dilara.
  • Sayan I; Sisli Hamidiye Etfal Training and Resourche Hospital, University of Health Sciences, 34371 Sisli, Istanbul, Turkey.
  • Altinay M; Sisli Hamidiye Etfal Training and Resourche Hospital, University of Health Sciences, 34371 Sisli, Istanbul, Turkey. Electronic address: m_altinay@yahoo.com.
  • Çinar AS; Sisli Hamidiye Etfal Training and Resourche Hospital, University of Health Sciences, 34371 Sisli, Istanbul, Turkey.
  • Türk HS; Sisli Hamidiye Etfal Training and Resourche Hospital, University of Health Sciences, 34371 Sisli, Istanbul, Turkey. Electronic address: hacersebnem@yahoo.com.tr.
  • Peker N; Sisli Hamidiye Etfal Training and Resourche Hospital, University of Health Sciences, 34371 Sisli, Istanbul, Turkey.
  • Sahin K; Sisli Hamidiye Etfal Training and Resourche Hospital, University of Health Sciences, 34371 Sisli, Istanbul, Turkey. Electronic address: krmshn@windowslive.com.
  • Coskun N; Sisli Hamidiye Etfal Training and Resourche Hospital, University of Health Sciences, 34371 Sisli, Istanbul, Turkey.
  • Demir GD; Sisli Hamidiye Etfal Training and Resourche Hospital, University of Health Sciences, 34371 Sisli, Istanbul, Turkey. Electronic address: dilarademir@windowslive.com.
Heart Lung ; 50(3): 425-429, 2021.
Artículo en Inglés | MEDLINE | ID: covidwho-1077912
ABSTRACT

BACKGROUND:

In Covid-19 pneumonia, high mortality rates reported in intubated patients have raised non-invasive methods of respiratory support.

OBJECTIVE:

We aimed to evaluate the impact of HFNC application on intubation requirement, intensive care length of stay, and short-term mortality in patients with COVID-19 pneumonia. MATERIAL-

METHOD:

Patients receiving oxygen by reservoir mask or HFNC therapy in our intensive care units due to COVID-19 pneumonia were included in the study. Group H consisted of patients who received HFNC, and Group K consisted of patients who received conventional oxygen therapy (COT). The number of patients intubated, duration of intensive care stay and short-term mortality were recorded.

RESULTS:

43 patients were included. The short-term mortality and the number of patients with intubation need was lower in Group H. There was no significant difference between the Groups in the length of intensive care stay.

CONCLUSION:

Administration of HFNC in respiratory failure secondary to COVID-19 pneumonia decreases the need for intubation and mortality.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Insuficiencia Respiratoria / COVID-19 Tipo de estudio: Estudio experimental / Ensayo controlado aleatorizado Límite: Humanos Idioma: Inglés Revista: Heart Lung Año: 2021 Tipo del documento: Artículo País de afiliación: J.hrtlng.2021.02.009

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Insuficiencia Respiratoria / COVID-19 Tipo de estudio: Estudio experimental / Ensayo controlado aleatorizado Límite: Humanos Idioma: Inglés Revista: Heart Lung Año: 2021 Tipo del documento: Artículo País de afiliación: J.hrtlng.2021.02.009